Clinitech Laboratory IPO Reservation
The Clinitech Laboratory IPO reservation is divided among different investor categories in accordance with SEBI regulations and the company's offer structure. A total of 6,02,400 equity shares are available for allocation across Retail Individual Investors (RIIs), and Others.
The Retail Individual Investor (RII) category has the highest allocation with 2,85,600 shares, representing 47.41% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 0 shares (%), while Non-Institutional Investors (NIIs) receive 0 shares (%).
The IPO also includes a reservation under Others, comprising 2,85,600 shares (47.41%). This category-wise reservation provides a clear view of how the IPO shares are distributed among eligible investor groups.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Market Maker | 31200 | 5.18 | 0 |
| Others | 285600 | 47.41 | 0 |
| Retail Investors | 285600 | 47.41 | 0 |
| Total | 602400 | 100 | 0 |
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the retail investor quota in the Clinitech Laboratory IPO?
The Retail Individual Investor (RII) quota in the Clinitech Laboratory IPO comprises 2,85,600 equity shares, representing 47.41% of the total IPO issue.
What is the category-wise reservation in the Clinitech Laboratory IPO?
The Clinitech Laboratory IPO reservation is divided as follows: Retail Individual Investors (RII): 2,85,600 shares (47.41%).
Is there a shareholder quota in the Clinitech Laboratory IPO?
No. The Clinitech Laboratory IPO does not include a shareholder reservation.